Johnson & Johnson vaccine could be approved by mid-March
Ireland would be entitled to 2.2 million doses of the single-shot vaccine
A new Covid-19 vaccine from Johnson & Johnson could be approved in Europe as early as mid-March following an application for authorisation to the European Medicines Agency (EMA) on Tuesday.
The new vaccine, developed by Johnson & Johnson subsidiary Janssen, would be the fourth vaccine available in Europe, but the first one that requires just a single dose.
The European Commission has ordered 200 million doses of the vaccine, of which Ireland will be entitled...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Government should begin delayed dosing programme this week, O‘Neill says
If the British 12-week delay strategy were applied to Ireland, it could result in 80 per cent of the adult population being vaccinated with a first dose by the end of May
Tony O’Brien: Our quarantine approach seems designed with failure in mind
The government needs to follow Britain’s example on border health measures, and to face down disgruntled EU states
Exemption to hotel quarantine sought for ‘essential’ engineers by business groups
Representatives of the pharma, medtech and dairy sectors have met with Nphet and the HSE to request changes to the mandatory hotel quarantining system
Danielle Barron on Covid-19: Celebrations across the water - are we nearly there yet?
As we gazed in envy at scenes of Britons socialising last week, it seemed like a different world. But experts say we’re not that far away ourselves